Skip to content

Evaluation of Pancreatobiliary Disorders in Patients With Altered Gastric Anatomy

Prospective Evaluation of Clinical Utility of Endoscopic Retrograde Cholangiopancreatography (ERCP) With Overtube in Patients With Altered Gastric Anatomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01238341
Enrollment
7
Registered
2010-11-10
Start date
2007-06-30
Completion date
2015-07-31
Last updated
2015-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Altered Gastric Anatomy, Pancreatobiliary Disease

Keywords

Pancreatobiliary disease in patients with altered gastric anatomy.

Brief summary

In patients, who have altered gastric anatomy and pancreatobiliary disease, the use of an endoscopic overtube to facilitate an Endoscopic Retrograde Cholangiopancreatography (ERCP).

Interventions

PROCEDUREEndoscopic Retrograde Cholangiopancreatography (ERCP)

An Endoscopic Retrograde Cholangiopancreatography (ERCP) performed with an overtube in the evaluation of pancreatobiliary disease in patients with altered gastric anatomy

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subject is 18 years or older 2. Subject has medical indication for Endoscopic Retrograde Cholangiopancreatography (ERCP) 3. Subject has altered gastric anatomy 4. Subject must be able to give informed consent.

Exclusion criteria

1. Any contraindication for Endoscopic Retrograde Cholangiopancreatography (ERCP) with overtube 2. The subject is unable to give informed consent

Design outcomes

Primary

MeasureTime frame
Papilla or Duct-enterostomy Was ReachedDuring procedure, up to 3 hours

Secondary

MeasureTime frameDescription
Successful Cannulation of the Duct of IntentDuring procedure, up to 3 hoursDeep cannulation of the bile/pancreatic duct was indicated in 12 of 13 ERCPs, one procedure was performed for stent removal only. This outcome was only relevant when deep cannulation was clinically indicated, therefore this outcome was determined out of 12 ERCPs.
Successful Endoscopic TherapyDuring procedure, up to 3 hours
Total Procedure TimeDuring procedure, up to 3 hours

Countries

United States

Participant flow

Participants by arm

ArmCount
Altered Gastric Anatomy
Patients with altered gastric anatomy that needed an Endoscopic Retrograde Cholangiopancreatography (ERCP) for endoscopic therapy of pancreatobiliary disease underwent ERCP with spiral overtube assisted enteroscopy.
7
Total7

Baseline characteristics

CharacteristicAltered Gastric Anatomy
Age, Continuous59.3 years
Indications for Endoscopic Retrograde Cholangiopancreatography (ERCP)
Bile duct stones
1 participants
Indications for Endoscopic Retrograde Cholangiopancreatography (ERCP)
Biliary obstruction
5 participants
Indications for Endoscopic Retrograde Cholangiopancreatography (ERCP)
Pancreatic leak
1 participants
Postsurgical anatomy
Billroth II gastrectomy w/ Braun enteroenterostomy
1 participants
Postsurgical anatomy
Roux-en-Y gastric bypass
3 participants
Postsurgical anatomy
Roux-en-Y gastric bypass with hepaticojejunostomy
1 participants
Postsurgical anatomy
Roux-en-Y hepaticojejunostomy
2 participants
Region of Enrollment
United States
7 participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 7
serious
Total, serious adverse events
0 / 7

Outcome results

Primary

Papilla or Duct-enterostomy Was Reached

Time frame: During procedure, up to 3 hours

ArmMeasureValue (NUMBER)
Altered Gastric AnatomyPapilla or Duct-enterostomy Was Reached10 ERCPs
Secondary

Successful Cannulation of the Duct of Intent

Deep cannulation of the bile/pancreatic duct was indicated in 12 of 13 ERCPs, one procedure was performed for stent removal only. This outcome was only relevant when deep cannulation was clinically indicated, therefore this outcome was determined out of 12 ERCPs.

Time frame: During procedure, up to 3 hours

ArmMeasureValue (NUMBER)
Altered Gastric AnatomySuccessful Cannulation of the Duct of Intent8 ERCPs
Secondary

Successful Endoscopic Therapy

Time frame: During procedure, up to 3 hours

ArmMeasureValue (NUMBER)
Altered Gastric AnatomySuccessful Endoscopic Therapy9 ERCPs
Secondary

Total Procedure Time

Time frame: During procedure, up to 3 hours

ArmMeasureValue (MEAN)
Altered Gastric AnatomyTotal Procedure Time95.6 minutes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026